» Articles » PMID: 26498439

Neurocognitive Effects of Proton Radiation Therapy in Adults with Low-grade Glioma

Overview
Journal J Neurooncol
Publisher Springer
Date 2015 Oct 27
PMID 26498439
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

To understand neurocognitive effects of proton radiation therapy (PRT) in patients with low-grade glioma, we evaluated 20 patients who received this therapy prospectively and over 5 years with a comprehensive neuropsychological battery. 20 patients were evaluated at baseline and at yearly intervals for up to 5 years with a battery of neuropsychological measures that assessed intellectual, attention, executive, visuospatial and memory functions as well as mood and functional status. We evaluated change in cognitive functioning over time. We analyzed the relationship between cognitive performance and tumor location and also examined whether patients' performance differed from that reported in a study of normative practice effects. Overall, patients exhibited stability in cognitive functioning. Tumor location played a role in performance; those with tumors in the left hemisphere versus in the right hemisphere were more impaired at baseline on verbal measures (p < .05). However, we found greater improvement in verbal memory over time in patients with left than with right hemisphere tumors (p < .05). Results of our study, the first to investigate, in depth, neurocognitive effects of PRT in adults with low-grade gliomas, are promising. We hypothesize that the conformal advantage of PRT may contribute to preservation of cognitive functioning, although larger sample sizes and a longer period of study are required. Our study also highlights the need to consider normative practice effects when studying neurocognitive functioning in response to treatment over time, and the need to utilize comprehensive neuropsychological batteries given our findings that differentiate patients with left and right hemisphere tumors.

Citing Articles

APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trial.

Slevin F, Hudson E, Boele F, Powell J, Noutch S, Borland M BMJ Open. 2025; 15(2):e097810.

PMID: 40010843 PMC: 11865786. DOI: 10.1136/bmjopen-2024-097810.


Neurocognitive function in lower grade glioma patients selected for proton radiotherapy: real-world data from a prospective cohort study.

van der Weide H, Buunk A, Siebenga F, Langendijk J, Bannink-Gawryszuk A, Bosma I J Neurooncol. 2025; .

PMID: 39976896 DOI: 10.1007/s11060-025-04973-7.


Symptom management in isocitrate dehydrogenase mutant glioma.

Walbert T, Avila E, Boele F, Hertler C, Lu-Emerson C, van der Meer P Neurooncol Pract. 2025; 12(Suppl 1):i38-i48.

PMID: 39776527 PMC: 11703367. DOI: 10.1093/nop/npae088.


Brain tumor-related epilepsy: an overview on neuropsychological, behavioral, and quality of life issues and assessment methodology.

Maschio M, Perversi F, Maialetti A Front Neurol. 2024; 15:1480900.

PMID: 39722690 PMC: 11668670. DOI: 10.3389/fneur.2024.1480900.


Proton Radiation Therapy: A Systematic Review of Treatment-Related Side Effects and Toxicities.

Salem P, Chami P, Daou R, Hajj J, Lin H, Chhabra A Int J Mol Sci. 2024; 25(20.

PMID: 39456752 PMC: 11506991. DOI: 10.3390/ijms252010969.


References
1.
Klein M, Heimans J, Aaronson N, VAN DER Ploeg H, Grit J, Muller M . Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet. 2002; 360(9343):1361-8. DOI: 10.1016/s0140-6736(02)11398-5. View

2.
Noll K, Sullaway C, Ziu M, Weinberg J, Wefel J . Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection. Neuro Oncol. 2014; 17(4):580-7. PMC: 4483071. DOI: 10.1093/neuonc/nou233. View

3.
Kaleita T, Wellisch D, Cloughesy T, Ford J, Freeman D, Belin T . Prediction of neurocognitive outcome in adult brain tumor patients. J Neurooncol. 2004; 67(1-2):245-53. DOI: 10.1023/b:neon.0000021900.29176.58. View

4.
Levin W, Kooy H, Loeffler J, DeLaney T . Proton beam therapy. Br J Cancer. 2005; 93(8):849-54. PMC: 2361650. DOI: 10.1038/sj.bjc.6602754. View

5.
Raysi Dehcordi S, Mariano M, Mazza M, Galzio R . Cognitive deficits in patients with low and high grade gliomas. J Neurosurg Sci. 2013; 57(3):259-66. View